Oculis SA entered into a Business Combination Agreement to acquire European Biotech Acquisition Corp. from Lsp Sponsor Ebac B.V. in a reverse merger for approximately $210 million.
BofA Securities is acting as financial advisor and SVB Securities is acting as capital market's advisor to Oculis. Xander lee, Elizabeth Anne Wright, Patrick Van Eecke, Matthew Pavao, Natasha Leskovsek, Bronwyn l. Roberts, Jennifer Shanley, Katie Kazem, Michal Berkner, Div Gupta, Ryan Sansom and Aaron Pomeroy of Cooley (UK) LLP acted as US legal advisors, VISCHER SA serves as Swiss legal counsel and PricewaterhouseCoopers SA serves as auditors to Oculis, SA. Credit Suisse and Kempen are acting as financial advisor and capital markets advisor. Michael Davis, Derek Dostal, Corey M. Goodman, David R. Bauer and Jennifer S. Conway of Davis Polk & Wardwell LLP acted as U.S. legal advisors, Stibbe N.V. serves as Dutch legal counsel, and Maples Group serves as Cayman legal counsel to EBAC.